
- Tissue
- 乳房
- Disease
- 乳腺癌
- Metastatic site
- 皮膚
- Synonyms
- Du4475, DU-4475, Du-4475, DU 4475, Du 4475, Duke University 4475
Documents
DU4475
Cell line · Product number 300371
The DU4475 cell line is a human breast cancer cell line derived from a metastatic site. It is characterized by its aggressive nature and poor differentiat...
Recommended (freshest lot)
01General information
- Description
DU4475 細胞系是一種源自轉移部位的人類乳癌細胞系。其特徵為侵襲性強且分化程度低,常被用於研究癌症轉移與進展的機制。 該細胞系已被廣泛應用於探索治療高度侵襲性乳腺癌類型的治療靶點及抗癌藥物療效。
從遺傳學角度來看,DU4475 展現出高度的遺傳不穩定性,這是許多癌細胞的標誌性特徵。此特徵使其成為研究導致癌症發生與進展之遺傳及分子事件的寶貴模型。 涉及 DU4475 的研究通常聚焦於調節癌細胞生長、存活及對化療耐藥性的途徑,使其成為旨在開發更有效癌症治療方法的腫瘤學研究中不可或缺的資源。
- Tissue
- 乳房
- Disease
- 乳腺癌
- Metastatic site
- 皮膚
- Applications
- 3D 細胞培養、免疫腫瘤學
- Synonyms
- Du4475
- DU-4475
- Du-4475
- DU 4475
- Du 4475
- Duke University 4475
02Classification
- Organism
- Human
- Sex
- Female
- Growth properties
- Suspension
- Biosafety level
- 1
03Characteristics
- Morphology
- 上皮性
- Tumourigenic
- 是的,在裸鼠身上
- Karyotype
- 人類扁平型近四倍體核型,具 12% 多倍體特徵 — 88-93<4n>xxxx, +1, +1, -5, -6, +9, -10, -10, +15, +15, -16, -16, +22, +4mar, i(1q)x2, ?add(1)(p35-36)x2, ?i(5p)x2, add(6)(p11), add(6)(p1?), del(6)(q25), add(9)(q35), del(11)(q24)x2, add(15)(p11)x2, add(17)(p1?)x2, del(21)(q22.2)x2 — 附帶 -20, -20, +del(7)(p11) — 典型於乳腺癌的 1q 增益與 6q 缺失 — 與已發表的核型相似
04Identifiers
- Citation
- DU4475(Cytion 型號 300371)
- NCBI TaxID
- 9606
- Cellosaurus
- CVCL_1183
05Expression and susceptibility
- Isoenzymes
- AK-1,1,ES-D,1,G6PD,B,GLO-I,2,Me-2,2,PGM1,1-2,PGM3,1
- Viruses
- EBV 陰性、HBV 陰性、HCV 陰性、HIV-1 陰性、HIV-2 陰性、HTLV-1/2 陰性、MLV 陰性、SMRV 陰性
06Handling and culture
- Culture medium
- RPMI 1640,含 2.0 mM 穩定谷氨醯胺,含 2.0 g/L NaHCO₃(Cytion 產品編號 820700a)
- Incubation atmosphere
37°C,5% CO₂,加濕環境。
- Supplements
- 在培養基中加入 15% 的熱滅活胎牛血清
- Subculturing
- 透過定期添加或更換培養基來維持培養。以 5 × 10⁵ 細胞/毫升的密度啟動培養,並將細胞濃度維持在 3 × 10⁵ 至 1 × 10⁶ 細胞/毫升的範圍內,以達到最佳生長效果。
- Thawing and culturing
Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.
Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.
For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.
Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.
Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.
Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.
Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.
Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
07Quality control and cryopreservation
- Sterility
透過基於 PCR 的檢測及基於發光原理的支原體檢測方法,排除支原體污染的可能性。
為確保無細菌、真菌或酵母菌污染,每日均會對細胞培養物進行目視檢查。
- Freeze medium
- 作為冷凍保存培養基,我們使用完全生長培養基(含 FBS)+ 10% DMSO 以確保解凍後的存活率,或使用 CM-1 (Cytion 型號 800100),該培養基含有經優化的滲透保護劑和代謝穩定劑,可提升細胞恢復率並減輕冷凍誘導的壓力。
- Storage conditions
若需長期保存,請將試管置於溫度約為 −150 至 −196 °C 的氣相液氮中。僅在轉移至液氮之前,可將試管暫時存放於 −80 °C 環境中,作為短期過渡步驟。
- Shipping conditions
冷凍保存的細胞系會以乾冰冷藏,並裝於經驗證的隔熱包裝中,包裝內含有足夠的冷媒,以確保在運輸過程中溫度維持在約 −78 °C。收到貨物後,請立即檢查容器,並盡快將試管轉移至適當的儲存場所。
08Donor
- Donor age
- 62年
- Ethnicity
- 歐洲的
09Legal and safety
- Safety precautions
- 若計劃將低溫試管存放在液態氮中以供日後解凍,必須嚴格遵守相關安全措施。 必須穿戴適當的防護手套和防護服,且在將冷凍樣本移入或移出液氮罐時,必須佩戴口罩或安全護目鏡。此舉旨在降低因取出時冷凍試管可能發生爆炸而導致受傷的風險,此類爆炸可能造成尖銳碎片飛濺。
- Warranty
在 Cytion,我們對產品的品質與存活率提供保障。 我們保證,自本公司設施出貨後 60 天內,我們的細胞在培養開始時仍具存活能力。 我們保證所有材料均符合 分析證明書及/或產品說明書中所載的規格。
詳情請參閱我們的 《保固聲明》。
- Material Transfer Agreement required
- Yes